Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Billich

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 20, 2002
4,4'-Benzophenone-O,O'-disulfamate: a potent inhibitor of steroid sulfatasePeter Nussbaumer, Melitta Bilban, Andreas Billich
Journal of Medicinal Chemistry|September 6, 2002
2-Substituted 4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatasePeter Nussbaumer, Philipp Lehr, Andreas Billich
Expert Opinion on Investigational Drugs|February 17, 2007
FTY720, an immunomodulatory sphingolipid mimetic: translation of a novel mechanism into clinical benefit in multiple sclerosisThomas Baumruker, Andreas Billich, Volker Brinkmann
Immunology Letters|December 9, 2004
The role of sphingosine and ceramide kinases in inflammatory responsesThomas Baumruker, Frédéric Bornancin, Andreas Billich
Journal of Medicinal Chemistry|October 31, 2003
Estrogenic potential of 2-alkyl-4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatasePeter Nussbaumer, Anthony P Winiski, Andreas Billich
International Journal of Pharmaceutics|December 31, 2003
Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimusAndreas Billich, Heinrich Aschauer, András Aszódi, et al.
Journal of Medicinal Chemistry|August 6, 2004
2-(1-adamantyl)-4-(thio)chromenone-6-carboxylic acids: potent reversible inhibitors of human steroid sulfataseAmarylla Horvath, Peter Nussbaumer, Barbara Wolff, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
N-Acyl arylsulfonamides as novel, reversible inhibitors of human steroid sulfatasePhilipp Lehr, Andreas Billich, Barbara Wolff, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2006
Constrained azacyclic analogues of the immunomodulatory agent FTY720 as molecular probes for sphingosine 1-phosphate receptorsStephen Hanessian, Guillaume Charron, Andreas Billich, et al.
Biochemical and Biophysical Research Communications|March 19, 2013
Assay to measure the secretion of sphingosine-1-phosphate from cells induced by S1P lyase inhibitorsErika Loetscher, Karolina Schneider, Christian Beerli, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|July 20, 2002
4,4'-Benzophenone-O,O'-disulfamate: a potent inhibitor of steroid sulfatasePeter Nussbaumer, Melitta Bilban, Andreas Billich
Journal of Medicinal Chemistry|September 6, 2002
2-Substituted 4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatasePeter Nussbaumer, Philipp Lehr, Andreas Billich
Expert Opinion on Investigational Drugs|February 17, 2007
FTY720, an immunomodulatory sphingolipid mimetic: translation of a novel mechanism into clinical benefit in multiple sclerosisThomas Baumruker, Andreas Billich, Volker Brinkmann
Immunology Letters|December 9, 2004
The role of sphingosine and ceramide kinases in inflammatory responsesThomas Baumruker, Frédéric Bornancin, Andreas Billich
Journal of Medicinal Chemistry|October 31, 2003
Estrogenic potential of 2-alkyl-4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatasePeter Nussbaumer, Anthony P Winiski, Andreas Billich
International Journal of Pharmaceutics|December 31, 2003
Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimusAndreas Billich, Heinrich Aschauer, András Aszódi, et al.
Journal of Medicinal Chemistry|August 6, 2004
2-(1-adamantyl)-4-(thio)chromenone-6-carboxylic acids: potent reversible inhibitors of human steroid sulfataseAmarylla Horvath, Peter Nussbaumer, Barbara Wolff, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
N-Acyl arylsulfonamides as novel, reversible inhibitors of human steroid sulfatasePhilipp Lehr, Andreas Billich, Barbara Wolff, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2006
Constrained azacyclic analogues of the immunomodulatory agent FTY720 as molecular probes for sphingosine 1-phosphate receptorsStephen Hanessian, Guillaume Charron, Andreas Billich, et al.
Biochemical and Biophysical Research Communications|March 19, 2013
Assay to measure the secretion of sphingosine-1-phosphate from cells induced by S1P lyase inhibitorsErika Loetscher, Karolina Schneider, Christian Beerli, et al.
Pageof 8